Live feed
Filing
SC 13G/A
SC 13G/A0000902664-19-000946·ADAGE CAPITAL PARTNERS GP, L.L.C.
Schedule 13G ownership disclosure
Xenon Pharmaceuticals Inc
Security class unavailable · CUSIP: 98420N105
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,300,000
- Percent of class
- 5.1500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-19-000946
- Form type
- SC 13G/A
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Feb 13, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership